To understand what a biobank is and why they exist, it helps first to understand what type of "currency" is stored in the "bank" and what this "currency" will be used to purchase. Biobanks are a collection of "biospecimens" (the "currency") and knowledge through research or preservation is often what can be "purchased" with this currency. And as a quick FYI, biobank and biorepository are words that can be used interchangeably to describe the same thing.
Biospecimens can be any type of biological sample or material. Seed biobanks, like the Svalbard Global Seed Bank in Norway, hold tens of thousands of seeds from over 4000 essential food crops. The purpose of this biobank is to function as a back-up for seeds being stored in various countries. If a crop is wiped out because of disease or a zombie apocalypse, these seeds can be used to grow these crops again a biobank.
The collection of birds, insects, butterflies, spiders and other animals and plants stored at the National Museum of Natural History at the Smithsonian Institute are also considered a biorepository. There are a few reasons that these types of collections exist. First, they are interesting to the public to show off the diversity of animals and plants found around the world and throughout time (I mean, who doesn't like dinosaurs?). But more than that, they are also immensely useful to scientists interesting in studying the animals themselves - including extinct animals, diversity, and evolution.
Biobanks that contain human tissue are most applicable to the study of humans and disease. The biospecimens stored in these biobanks may include urine, blood, tissue (for example, extra tumor tissue removed during a surgery), feces (aka poop), cells (for example, cells scraped from the inside of the cheek or skin cells), cerebral spinal fluid, DNA or RNA. The purpose of repositories that store tissue and fluids from people is to better understand diseases and use this understanding to develop molecular diagnostics and treatments. How is this done? Generally, scientists will compare biospecimens from many patients with a particular disease (for example, tumor tissue removed during surgery from patients with breast cancer or blood from patients with diabetes) to samples from patients who do not have that disease using one of those "-omic" analyses. Through understanding what causes the disease, methods can be devised to better detect the disease early or treatments can be developed to target the cause.
But you may be wondering how tissue biorepositories exist at all? It is all because patients have been gracious enough to contribute some tissue, blood, skin, or nails for researchers to use in their research. Biorepositories do not own this tissue and neither do the researchers - we are merely custodians of the tissue with the ultimate purpose to use the biospecimens for research. The patient always comes first. Therefore, the first thing that is done before collecting tissue for research is to talk to the patient and explain why it is biobankers would like to collect and store their tissue. The risks are explained and we ask for their permission through a process called informed consent (more on this in future posts). If a patient does not consent to donate tissue for research, this does not affect their care in any way whatsoever. It is the patients choice. However, if they do agree to donate tissue, it will either be collected in the operating room (in the case of tumor tissue) or in pathology. This tissue collection never disrupts medical care or diagnosis. If all of the tissue is needed for diagnosing the patient, then that's what happens and none is collected for research. Again, the patient and their medical care always come first. If we are able to collect samples, they are stored in liquid nitrogen tanks until they are requested by a researcher. We then make sure that the samples safely get to the researcher.
Thousands (likely hundreds of thousands) of studies have relied on biospecimens to better understand the underlying disease in or to develop treatments. For example, tissue from melanoma patients was used to identify a mutation found ~50% of patients who have melanoma. This mutation can be specifically targeted by a drug that significantly improved progression-free survival in patients who typically have a dismal prognosis. Even more studies on ongoing, with the goal of using knowledge gained from these priceless biospecimens to reach the promise of personalized medicine.
Dr. Cathy Seiler is the Program Manager for the tissue biorepository at St. Joseph's Hospital and Barrow Neurological Institute. She has her BA in Biochemistry and Molecular Biology from Boston University and PhD in the Biological Sciences from Cold Spring Harbor Laboratory. Her research and teaching focuses on genetics, cancer, and personalized medicine. Find her on Facebook at www.facebook.com/thingsitellmymom